On the other hand, the risk of developing male breast cancer, prostate cancer, pancreatic cancer, and melanoma in BRCA2 mutation carriers has been reported to be higher than in BRCA1 [26]. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.